Yohann Loriot

Yohann Loriot

UNVERIFIED PROFILE

Are you Yohann Loriot?   Register this Author

Register author
Yohann Loriot

Yohann Loriot

Publications by authors named "Yohann Loriot"

Are you Yohann Loriot?   Register this Author

100Publications

4067Reads

30Profile Views

Studying Rarity in Bladder Cancer.

Eur Urol 2020 Apr 5;77(4):447-448. Epub 2019 Dec 5.

Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, Université Paris-Sud, Université Paris-Saclay, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.11.018DOI Listing
April 2020

Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome.

Eur J Cancer 2020 Apr 6;129:117-122. Epub 2020 Mar 6.

Gustave Roussy, Université Paris-Saclay, Oncology Medicine Department, Villejuif, F-94805, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2020.01.017DOI Listing
April 2020

Facts and New Hopes on Selective FGFR Inhibitors in Solid Tumors.

Clin Cancer Res 2020 Feb 4;26(4):764-774. Epub 2019 Oct 4.

INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-2035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024606PMC
February 2020

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees.

Authors:
J Alfred Witjes Marek Babjuk Joaquim Bellmunt H Maxim Bruins Theo M De Reijke Maria De Santis Silke Gillessen Nicholas James Steven Maclennan Juan Palou Tom Powles Maria J Ribal Shahrokh F Shariat Theo Van Der Kwast Evanguelos Xylinas Neeraj Agarwal Tom Arends Aristotle Bamias Alison Birtle Peter C Black Bernard H Bochner Michel Bolla Joost L Boormans Alberto Bossi Alberto Briganti Iris Brummelhuis Max Burger Daniel Castellano Richard Cathomas Arturo Chiti Ananya Choudhury Eva Compérat Simon Crabb Stephane Culine Berardino De Bari Willem De Blok Pieter J L De Visschere Karel Decaestecker Konstantinos Dimitropoulos Jose L Dominguez-Escrig Stefano Fanti Valerie Fonteyne Mark Frydenberg Jurgen J Futterer Georgios Gakis Bogdan Geavlete Paolo Gontero Bernhard Grubmüller Shaista Hafeez Donna E Hansel Arndt Hartmann Dickon Hayne Ann M Henry Virginia Hernandez Harry Herr Ken Herrmann Peter Hoskin Jorge Huguet Barbara A Jereczek-Fossa Rob Jones Ashish M Kamat Vincent Khoo Anne E Kiltie Susanne Krege Sylvain Ladoire Pedro C Lara Annemarie Leliveld Estefania Linares-Espinós Vibeke Løgager Anja Lorch Yohann Loriot Richard Meijer M Carmen Mir Marco Moschini Hugh Mostafid Arndt-Christian Müller Christoph R Müller James N'Dow Andrea Necchi Yann Neuzillet Jorg R Oddens Jan Oldenburg Susanne Osanto Wim J G Oyen Luís Pacheco-Figueiredo Helle Pappot Manish I Patel Bradley R Pieters Karin Plass Mesut Remzi Margitta Retz Jonathan Richenberg Michael Rink Florian Roghmann Jonathan E Rosenberg Morgan Rouprêt Olivier Rouvière Carl Salembier Antti Salminen Paul Sargos Shomik Sengupta Amir Sherif Robert J Smeenk Anita Smits Arnulf Stenzl George N Thalmann Bertrand Tombal Baris Turkbey Susanne Vahr Lauridsen Riccardo Valdagni Antoine G Van Der Heijden Hein Van Poppel Mihai D Vartolomei Erik Veskimäe Antoni Vilaseca Franklin A Vives Rivera Thomas Wiegel Peter Wiklund Andrew Williams Richard Zigeuner Alan Horwich

Eur Urol 2020 Feb 19;77(2):223-250. Epub 2019 Nov 19.

Emeritus Professor, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.09.035DOI Listing
February 2020

[Stage 1 germ-cell tumour].

Bull Cancer 2019 Oct 12;106(10):887-895. Epub 2019 May 12.

Gustave Roussy, département de médecine oncologique, 114, rue Edouard-Vaillant, 94805 Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2019.03.010DOI Listing
October 2019

Erdafitinib in Urothelial Carcinoma. Reply.

N Engl J Med 2019 10;381(16):1594-1595

University of Texas M.D. Anderson Cancer Center, Houston, TX

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1911187DOI Listing
October 2019

Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review.

J Clin Med 2019 Aug 8;8(8). Epub 2019 Aug 8.

Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, 75006 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8081190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722659PMC
August 2019

Effect of Immunotherapy on Local Treatment of Genitourinary Malignancies.

Eur Urol Oncol 2019 Jul 31;2(4):355-364. Epub 2019 Jan 31.

Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.01.002DOI Listing
July 2019

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.

N Engl J Med 2019 07;381(4):338-348

From Gustave Roussy, INSERM Unité 981, Université Paris-Sud, Université Paris-Saclay, Villejuif, France (Y.L.); Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (A.N.); Sungkyunkwan University Samsung Medical Center, Seoul, South Korea (S.H.P.); Genitourinary and Gynecological Cancer Unit, Centro Integral Oncológico Clara Campal, Madrid (J.G.-D.), Hospital Clinic Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona (B.M.), and Hospital Universitario Marques de Valdecilla, Santander (I.D.) - all in Spain; the Institute of Cancer Research, Sutton, London (R.H.); the Levine Cancer Institute, Atrium Health, Charlotte, NC (E.B.); Virginia Oncology Associates, US Oncology Research, Norfolk (M.F.); Norton Healthcare, Louisville, KY (A.R.); the Altai Regional Cancer Center, Barnaul, Russia (S.V.); the Penn State Cancer Institute, Hershey (M.J.), and Janssen Research and Development, Spring House (B.Z., A.S.-W., A.O., A.A.) - both in Pennsylvania; Weill Cornell Medical College, New York (S.T.T.); University of Iowa Hospitals and Clinics, Holden Comprehensive Cancer Center, Iowa City (Y.Z.); Janssen Research and Development, Beerse, Belgium (K.S., P.D.P.); and the University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1817323DOI Listing
July 2019

A Case of Heavily Pretreated Metastatic Germ Cell Tumor With Ongoing Long-term Complete Response After Gemcitabine Treatment.

Clin Genitourin Cancer 2019 06 26;17(3):e485-e487. Epub 2019 Jan 26.

Department of Cancer Medicine, Gustave Roussy, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.01.010DOI Listing
June 2019

[DNA damage repair: An emerging strategy in metastatic prostate cancer].

Bull Cancer 2018 Oct 29;105(10):944-954. Epub 2018 Sep 29.

CHU de Besançon, oncologie, 25030 Besançon cedex, France; Inserm, UMR1098, 25020 Besançon cedex, France; Université de Franche-Comté, UMR1098, SFR IBCT, 25020 Besançon, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00074551183022
Publisher Site
http://dx.doi.org/10.1016/j.bulcan.2018.05.017DOI Listing
October 2018

Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment.

J Clin Oncol 2018 09 20;36(25):2639-2646. Epub 2018 Jul 20.

Gerhardt Attard, The Institute of Cancer Research and the Royal Marsden National Health Service Foundation Trust, London, United Kingdom; Michael Borre, Aarhus University Hospital, Aarhus, Denmark; Howard Gurney, Macquarie University, Sydney, New South Wales, Australia; Yohann Loriot, Gustave Roussy, Institut National de la Santé et de la Recherche Médicale U981, University of Paris Saclay, Villejuif, France; Corina Andresen-Daniil, Ranjith Kalleda, and Trinh Pham, Pfizer, New York, NY; and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.77.9827DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118405PMC
September 2018

Role of Checkpoint Inhibition in Localized Bladder Cancer.

Eur Urol Oncol 2018 08 30;1(3):190-198. Epub 2018 May 30.

Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2018.05.002DOI Listing
August 2018

Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients.

J Immunother Cancer 2017 18;5:31. Epub 2017 Apr 18.

Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-017-0232-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394619PMC
June 2018

Durvalumab in urothelial cancers.

Expert Rev Anticancer Ther 2018 04 5;18(4):311-318. Epub 2018 Mar 5.

b Drug Development Department (DITEP), Gustave Roussy , Université Paris-Sud, Université Paris-Saclay , Villejuif , France.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2018.1443812DOI Listing
April 2018

Atezolizumab in urothelial bladder carcinoma.

Future Oncol 2018 Feb 14;14(4):331-341. Epub 2017 Nov 14.

Department de Médecine Oncologique & INSERM U981, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0433DOI Listing
February 2018

[Atezolizumab (Tecentriq): Activity, indication and modality of use in advanced or metastatic urinary bladder carcinoma].

Bull Cancer 2018 Feb 28;105(2):140-145. Epub 2017 Dec 28.

University of Paris Sud, Gustave Roussy cancer campus, drug development department, 94805 Villejuif cedex, France; University of Paris Sud, Gustave Roussy cancer campus, department of medical oncology, 94805 Villejuif cedex, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00074551173038
Publisher Site
http://dx.doi.org/10.1016/j.bulcan.2017.10.030DOI Listing
February 2018

Everolimus Versus Axitinib as Second-line Therapy in Metastatic Renal Cell Carcinoma: Experience From Institut Gustave Roussy.

Clin Genitourin Cancer 2017 12 12;15(6):e1081-e1088. Epub 2017 Aug 12.

Department of Medical Oncology, Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.07.015DOI Listing
December 2017

Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours.

Eur J Cancer 2016 12 4;69:151-157. Epub 2016 Nov 4.

Department of Cancer Medicine, Institut Gustave Roussy, Université Paris-Sud, 94800 Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.10.003DOI Listing
December 2016

Safety of available treatment options for renal cell carcinoma.

Expert Opin Drug Saf 2016 Aug 23;15(8):1097-106. Epub 2016 May 23.

a Gustave Roussy Cancer Campus.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2016.1184643DOI Listing
August 2016

Early PSA response is an independent prognostic factor in patients with metastatic castration-resistant prostate cancer treated with next-generation androgen pathway inhibitors.

Eur J Cancer 2016 07 3;61:44-51. Epub 2016 May 3.

Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.03.070DOI Listing
July 2016

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

EMBO Mol Med 2016 07 1;8(7):761-78. Epub 2016 Jul 1.

The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15252/emmm.201506059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931290PMC
July 2016

ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer.

Expert Rev Anticancer Ther 2015 ;15(9):1007-17

a Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2015.1081566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673554PMC
May 2016

Nonfamilial Chronic Serum Alpha-Fetoprotein Increase in a Patient With Clinical Stage I Seminoma.

Clin Genitourin Cancer 2016 Feb 17;14(1):e91-3. Epub 2015 Aug 17.

Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.07.014DOI Listing
February 2016

Novel therapeutic targets in advanced urothelial carcinoma.

Crit Rev Oncol Hematol 2016 Feb 9;98:106-15. Epub 2015 Nov 9.

INSERM U981, Gustave Roussy Cancer Campus, Paris-South University, Villejuif, France; Drug Development Department, Gustave Roussy Cancer Campus, Paris-South University, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.10.021DOI Listing
February 2016

Acquired EGFR Mutation as the Potential Resistance Driver to Crizotinib in a MET-Mutated Tumor.

J Thorac Oncol 2016 Feb 18;11(2):e21-3. Epub 2015 Dec 18.

DITEP (Département d'Innovations Thérapeutiques et Essais Précoces), Gustave Roussy Cancer Campus, Villejuif, France; Faculté de médicine Paris-Sud XI, Kremlin-Bicêtre, France; U981 INSERM, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.08.001DOI Listing
February 2016

Long-term Efficacy and Safety Results: Can Enzalutamide Challenge the Dogma of Androgen Deprivation Therapy in Hormone-naïve Prostate Cancer?

Eur Urol 2015 Nov 24;68(5):802-4. Epub 2015 Apr 24.

Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.04.019DOI Listing
November 2015

High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting.

Eur J Cancer 2015 Nov 13;51(17):2570-7. Epub 2015 Aug 13.

Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, University of Paris Sud, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.07.042DOI Listing
November 2015

Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancer.

Eur J Cancer 2015 Sep 21;51(14):1946-52. Epub 2015 Jul 21.

Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.06.128DOI Listing
September 2015

Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies.

Eur Urol 2015 Aug 2;68(2):228-35. Epub 2014 May 2.

Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.04.015DOI Listing
August 2015

Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome.

Urol Oncol 2015 May 5;33(5):202.e9-17. Epub 2015 Mar 5.

Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.01.022DOI Listing
May 2015

Efficacy outcomes by baseline prostate-specific antigen quartile in the AFFIRM trial.

Eur Urol 2015 Feb 27;67(2):223-30. Epub 2014 Aug 27.

Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.08.025DOI Listing
February 2015

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.

Nature 2014 Nov;515(7528):558-62

University of Nevada School of Medicine and US Oncology/Comprehensive Cancer Centers of Nevada, 3730 S. Eastern Avenue, Las Vegas, Nevada 89169, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature13904DOI Listing
November 2014

One size does not fit all: can we choose the best sequence of treatment in asymptomatic castration-resistant prostate cancer patients?

Eur Urol 2014 Oct 31;66(4):653-4. Epub 2014 Mar 31.

Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838140027
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2014.03.024DOI Listing
October 2014

Compliance with guidelines and correlation with outcome in patients with advanced germ-cell tumours.

Eur J Cancer 2014 May 20;50(7):1284-90. Epub 2014 Feb 20.

Department of Cancer Medicine, University of Paris Sud, Institut Gustave Roussy, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.01.026DOI Listing
May 2014

[Abiraterone acetate (AA): current guidelines of prescription of abiraterone].

Bull Cancer 2014 Apr;101(4):388-93

Institut Gustave-Roussy, DITEP, Département d'innovations thérapeutiques et essais précoces, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2014.1932DOI Listing
April 2014

Towards random sequencing or precision medicine in castration-resistant prostate cancer?

Eur Urol 2014 Jan 19;65(1):37-8. Epub 2013 Sep 19.

Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris Sud, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2013.09.019DOI Listing
January 2014

Taxanes: still a major weapon in the armamentarium against prostate cancer.

Eur Urol 2013 Jun 21;63(6):983-5. Epub 2013 Jan 21.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2013.01.016DOI Listing
June 2013

Targeted therapy-induced radiation recall.

Eur J Cancer 2013 May 8;49(7):1662-8. Epub 2013 Jan 8.

Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.12.009DOI Listing
May 2013

Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients.

Eur J Cancer 2013 May 13;49(8):1898-904. Epub 2013 Mar 13.

Department of Medical Oncology, Gustave Roussy Institute, Paris XI University, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.02.003DOI Listing
May 2013

Stem cell tracking: toward clinical application in oncology?

Tumori 2012 Sep-Oct;98(5):535-42

UPRES EA 2710, Gustave Roussy Institute, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1700/1190.13192DOI Listing
February 2013

Targeted therapies in metastatic castration-resistant prostate cancer: beyond the androgen receptor.

Urol Clin North Am 2012 Nov 1;39(4):517-31. Epub 2012 Sep 1.

Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2012.07.008DOI Listing
November 2012

Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum-gemcitabine regimen.

Eur J Cancer 2012 May 22;48(8):1141-6. Epub 2012 Feb 22.

Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, 39 rue Camille Desmoulins, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.01.022DOI Listing
May 2012

Minimal residual disease in solid neoplasia: New frontier or red-herring?

Cancer Treat Rev 2012 Apr 25;38(2):101-10. Epub 2011 May 25.

Institut Gustave Roussy, Université Paris, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2011.04.014DOI Listing
April 2012

Carcinomas of an unknown primary origin--diagnosis and treatment.

Nat Rev Clin Oncol 2011 Nov 1;8(12):701-10. Epub 2011 Nov 1.

Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 39 rue Camille Desmoulins, F-94800 Villejuif, France. christophe.massard@ igr.fr

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2011.158DOI Listing
November 2011

Lung cancer stem cell: new insights on experimental models and preclinical data.

J Oncol 2011 16;2011:549181. Epub 2010 Dec 16.

Laboratoire UPRES EA 27-10 "Radiosensibilité des Tumeurs et Tissus Sains", Institut Gustave Roussy, 39 rue Camille Desmoulins, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/549181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010697PMC
July 2011